Aldeyra Therapeutics

Filed a patent for "methotrexate treatment methods" on Wed, June 28, 2023

Filed a patent for "heterocyclic aldehyde trapping compounds and uses thereof" on Fri, December 8, 2023

Filed a patent for "deuterated compounds and uses thereof" on Thu, June 8, 2023

Filed a patent for "quinoline compounds for treating respiratory disorders and viral infections" on Thu, April 27, 2023

Filed a patent for "modified cyclodextrins and ophthalmic uses thereof" on Fri, October 28, 2022

Filed a patent for "dry eye disease biomarkers and their use for treatment" on Thu, July 20, 2023

Filed a patent for "methotrexate treatment methods" on Wed, December 14, 2022

Filed a patent for "treatment of inflammatory disorders" on Thu, August 10, 2023

Filed a patent for "quinoline compounds for treating lung, liver, and kidney diseases, disorders, or conditions" on Thu, May 18, 2023

Filed a patent for "treatment of inflammatory disorders" on Thu, September 21, 2023

Filed a patent for "compositions and methods of treating retinal disease" on Thu, May 30, 2024

Filed a patent for "toxic aldehyde related diseases and treatment" on Thu, June 13, 2024

Filed a patent for "compositions and methods for the treatment of macular degeneration" on Thu, May 9, 2024

Filed a patent for "ophthalmic formulations and uses thereof" on Thu, May 2, 2024

Filed a patent for "deuterated compounds and uses thereof" on Thu, April 25, 2024

Filed a patent for "methotrexate treatment methods" on Thu, June 20, 2024

Filed a patent for "methods of treating sjögren-larssen syndrome" on Tue, March 29, 2022

Filed a patent for "compositions and methods of treating retinal disease" on Thu, February 9, 2023

Filed a patent for "ophthalmic formulations of methotrexate" on Thu, January 19, 2023

Filed a patent for "ophthalmic formulations of methotrexate" on Thu, January 19, 2023